Clinical Trial Update: Study of Smith-Lemli-Opitz Syndrome

View source ↗

Summary

A NICHD-sponsored clinical trial investigating Smith-Lemli-Opitz Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smith-lemli-opitz Syndrome

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Smith-Lemli-Opitz Syndrome | Status: COMPLETED